+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Presence and severity of Chlamydia pneumoniae and Cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes

Presence and severity of Chlamydia pneumoniae and Cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes

International Heart Journal 47(4): 511-519

Although an association between Chlamydia pneunioniae (Cpn) or Cytomegalovirus (CMV) infection and coronary atherosclerosis has been reported, such an association is less clear for acute coronary syndromes (ACS). The purpose of this study was to investigate the pathogenic roles of Cpn and CMV infection of coronary. plaques in ACS.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 012444599

Download citation: RISBibTeXText

PMID: 16960406

Related references

Chlamydia pneumoniae immunoreactivity in coronary artery plaques of patients with acute coronary syndromes and its relation with serology. American Heart Journal 150(4): 681-688, 2005

Does chronic infection with Chlamydia pneumoniae influence the prognosis of acute coronary syndromes? Insights from a nested matched case-control substudy of the GUSTO IV acute coronary syndromes Trial. Journal of the American College of Cardiology 43(5 Suppl. A): 257A, 2004

No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial. American Heart Journal 154(2): 306-312, 2007

Relationship of Chlamydia pneumoniae infection to severity of coronary atherosclerosis in patients with chronic coronary artery disease and with normal coronary arteries. Journal of Cardiology 37(6): 293-299, 2001

Association between Chlamydia pneumoniae infection and acute coronary syndromes. Atherosclerosis 144(Supp-S1): 122-123, 1999

The influence of Chlamydia pneumoniae infection on acute coronary syndromes. Polski Merkuriusz Lekarski 15(85): 20-23, 2003

Chlamydia pneumoniae in coronary plaques: Increased detection with acute coronary syndrome. Deutsche Medizinische Wochenschrift 124(13): 375-380, 1999

Serologic evidence of current Chlamydia pneumoniae infection in acute coronary syndromes. Canadian Journal of Cardiology 16(Suppl. F): 161F, 2000

Lack of association of Bartonella sp, Coxiella burnetii and Chlamydia pneumoniae infection with acute coronary syndromes. Abstracts of the General Meeting of the American Society for Microbiology 101: 233-234, 2001

Chlamydia pneumoniae infection does not correlate with the severity of coronary artery disease and does not predict the risk of restenosis after percutaneous transluminal coronary angioplasty. European Heart Journal 19(ABST Suppl. ): 395, 1998

Relation of secretory phospholipase A(2) and high-sensitivity C-reactive protein to Chlamydia pneumoniae infection in acute coronary syndromes. Circulation Journal 68(7): 628-633, 2004

Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes. American Heart Journal 144(6): 987-994, 2002

Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques. Heart 91(4): 521-525, 2005

Lp levels are related to the presence and severity of angiographic coronary artery disease but not to the occurrence of acute coronary syndromes. European Heart Journal 14(ABSTR Suppl. ): 365, 1993

Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability. International Journal of Cardiology 147(1): 176-178, 2011